MedPath

A study to see the difference in doses received to tumour and normal organs in patients undergoing prostate radiotherapy by two different techniques Volumetric modulated Arc Therapy (VMAT)and Intensity Modulated radiotherapy(IMRT).

Not Applicable
Recruiting
Conditions
Health Condition 1: null- DIAGNOSED CASE OF CA PROSTATE, ELIGIBLE FOR RADICAL RADIOTHERAPY
Registration Number
CTRI/2011/11/002121
Lead Sponsor
MedantaThe Medicity
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

1. Histologically proven prostate adenocarcinoma

2. Clinical stage T1-T3, N0-N1, M0 (Patients beyond T1-T2c will be taken after complete androgen blockade for 2 months

3. No prior radical surgery or cryosurgery for prostate cancer

Exclusion Criteria

Not provided

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath